secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0000950170-24-036403
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex reports Q4 2023 revenue of $12.5M, net loss of $3.0M; full-year revenue down 9%
--------------------------------------------------------------------------------

- Q4 2023 total revenue $12.5M vs $15.2M YoY; net loss $3.0M ($0.18 per share) vs $1.1M loss in Q4 2022.
- Full-year 2023 revenue $51.9M (down 9% from $57.0M); net loss $9.6M ($0.59 per share) vs $7.5M loss in 2022.
- Cyclo G6 product family Q4 revenue $3.0M (down 29%); sold 12,700 probes vs 16,400 a year ago.
- Strategic review ongoing; management expects to reach first asset sale agreement soon.
- Cash use reduced to $1.0M in Q4; cash and equivalents $7.0M at year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017024036403/0000950170-24-036403-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017024036403/irix-20240326.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-036403

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer